X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1771) 1771
Book Review (362) 362
Publication (252) 252
Book Chapter (10) 10
Conference Proceeding (6) 6
Magazine Article (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1481) 1481
humans (1245) 1245
daptomycin (1124) 1124
anti-bacterial agents - therapeutic use (910) 910
pharmacology & pharmacy (748) 748
microbiology (721) 721
daptomycin - therapeutic use (691) 691
infectious diseases (652) 652
vancomycin (642) 642
anti-bacterial agents - pharmacology (555) 555
male (526) 526
staphylococcal infections - drug therapy (509) 509
microbial sensitivity tests (491) 491
female (443) 443
antibiotics (410) 410
daptomycin - pharmacology (390) 390
middle aged (371) 371
bacteremia (364) 364
staphylococcus aureus (341) 341
staphylococcal infections - microbiology (332) 332
aged (316) 316
infections (312) 312
linezolid (298) 298
treatment outcome (298) 298
methicillin-resistant staphylococcus aureus - drug effects (295) 295
adult (282) 282
gram-positive bacterial infections - drug therapy (278) 278
endocarditis (277) 277
animals (273) 273
staphylococcus aureus - drug effects (270) 270
vancomycin - therapeutic use (260) 260
anti-bacterial agents - administration & dosage (243) 243
bacteremia - drug therapy (233) 233
resistant staphylococcus-aureus (224) 224
therapy (209) 209
daptomycin - administration & dosage (201) 201
drug resistance (199) 199
staphylococcus infections (199) 199
staphylococcus-aureus (198) 198
vancomycin - pharmacology (197) 197
health aspects (188) 188
biochemical phenomena, metabolism, and nutrition (185) 185
drug resistance, bacterial (184) 184
mrsa (179) 179
methicillin-resistant staphylococcus aureus (178) 178
anti-bacterial agents - adverse effects (176) 176
retrospective studies (176) 176
staphylococcus aureus infections (176) 176
gram-positive bacterial infections - microbiology (170) 170
bacteremia - microbiology (168) 168
drug resistance in microorganisms (163) 163
aged, 80 and over (160) 160
efficacy (159) 159
susceptibility (156) 156
anti-bacterial agents - pharmacokinetics (154) 154
infectious disease (153) 153
endocarditis, bacterial - drug therapy (150) 150
bacterial infections and mycoses (143) 143
drug therapy (143) 143
care and treatment (141) 141
antimicrobial agents (139) 139
daptomycin - adverse effects (139) 139
internal medicine (135) 135
pharmacokinetics (135) 135
vancomycin resistance (134) 134
bacteria (133) 133
drug therapy, combination (133) 133
methicillin-resistant (132) 132
antibacterial agents (128) 128
immunology (124) 124
research (123) 123
methicillin-resistant staphylococcus aureus - isolation & purification (121) 121
methicillin resistance (120) 120
resistance (119) 119
oxazolidinones - therapeutic use (116) 116
daptomycin - pharmacokinetics (115) 115
tigecycline (115) 115
minimum inhibitory concentration (113) 113
bactericidal activity (112) 112
in-vitro (110) 110
infection (110) 110
analysis (109) 109
endocarditis, bacterial - microbiology (109) 109
mortality (109) 109
safety (109) 109
gram-positive bacteria (108) 108
acetamides - therapeutic use (105) 105
complicated skin (102) 102
gram-positive infections (100) 100
combination (96) 96
risk factors (93) 93
pharmacology (92) 92
skin-structure infections (92) 92
infective endocarditis (85) 85
polycyclic compounds (85) 85
strains (85) 85
management (83) 83
young adult (83) 83
pathogens (82) 82
blood-stream infections (81) 81
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1679) 1679
Spanish (58) 58
French (12) 12
Italian (7) 7
Turkish (7) 7
German (5) 5
Chinese (4) 4
Japanese (3) 3
Russian (2) 2
Croatian (1) 1
Danish (1) 1
Dutch (1) 1
Finnish (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2006, Volume 355, Issue 7, pp. 653 - 665
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2013, Volume 57, Issue 2, pp. 855 - 863
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
SOFT-TISSUE INFECTIONS | STREPTOCOCCUS-PYOGENES | DOSE PHARMACOKINETICS | ANTIBACTERIAL ACTIVITY | MOUSE MODEL | ECONOMIC OUTCOMES | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | LENGTH-OF-STAY | MURINE THIGH INFECTION | COMPLICATED SKIN | TRIMETHOPRIM-SULFAMETHOXAZOLE | Linezolid | Skin - microbiology | Mupirocin - administration & dosage | Male | Luminescent Measurements | Mupirocin - therapeutic use | Oxazolidinones - administration & dosage | Skin - injuries | Oxazolidinones - therapeutic use | Anti-Bacterial Agents - therapeutic use | Doxycycline - administration & dosage | Staphylococcal Skin Infections - drug therapy | Acetamides - therapeutic use | Bridged Bicyclo Compounds, Heterocyclic - therapeutic use | Clindamycin - administration & dosage | Community-Acquired Infections - drug therapy | Diabetes Mellitus, Type 2 | Soft Tissue Infections - drug therapy | Staphylococcal Infections - microbiology | Wound Healing - drug effects | Daptomycin - therapeutic use | Disease Models, Animal | Staphylococcal Infections - drug therapy | Vancomycin - administration & dosage | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Administration, Oral | Doxycycline - therapeutic use | Methicillin-Resistant Staphylococcus aureus - drug effects | Mice, Inbred C57BL | Bridged Bicyclo Compounds, Heterocyclic - administration & dosage | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Bacterial Load | Clindamycin - therapeutic use | Animals | Soft Tissue Infections - microbiology | Vancomycin - therapeutic use | Mice | Administration, Topical | Anti-Bacterial Agents - administration & dosage | Community-Acquired Infections - microbiology | Staphylococcal Skin Infections - microbiology | Daptomycin - administration & dosage | Acetamides - administration & dosage | Index Medicus | Animal models | Bioluminescence | Intravenous administration | Image processing | Clindamycin | Vancomycin | Cellulitis | Drug resistance | Polyethylene glycol | Surgery | daptomycin | Ointments | Wound infection | Wound healing | Diabetes mellitus | Antimicrobial agents | Folliculitis | Mupirocin | imaging | Soft tissues | Drainage | Photography | Antibiotics | trimethoprim-sulfamethoxazole | Ulcers | Doxycycline | Impetigo | Skin | Experimental Therapeutics
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 6/2013, Volume 56, Issue 11, pp. 1562 - 1569
Background. Recent reports have described decreased effectiveness with vancomycin treatment for methicillin-resistant Staphylococcus aureus bacteremia (MRSAB)... 
Trucks | Intensive care units | Health outcomes | Infectious diseases | Primary literature | Mortality | Methicillin resistant staphylococcus aureus | Infections | ARTICLES AND COMMENTARIES | Bacteremia | Staphylococcus aureus | daptomycin | methicillin-resistant Staphylococcus aureus | vancomycin | bacteremia | MORTALITY | INFECTIOUS DISEASES | AMERICA | GUIDELINES | MICROBIOLOGY | IMMUNOLOGY | THERAPY | OUTCOMES | ENDOCARDITIS | INFECTIOUS-DISEASES SOCIETY | Multivariate Analysis | Staphylococcal Infections - drug therapy | Humans | Methicillin-Resistant Staphylococcus aureus - drug effects | Middle Aged | Bacteremia - drug therapy | Proportional Hazards Models | Male | Treatment Outcome | Chi-Square Distribution | Bacteremia - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Daptomycin - pharmacology | Vancomycin - therapeutic use | Vancomycin - pharmacology | Adult | Female | Anti-Bacterial Agents - pharmacology | Staphylococcal Infections - microbiology | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Cohort Studies | Daptomycin - therapeutic use | Patient outcomes | Dosage and administration | Research | Vancomycin | Drug therapy | Comparative analysis | Staphylococcus infections | Regression analysis | Antibiotics | Primary care | Clinical outcomes | Index Medicus | Indexing in process
Journal Article
Journal Article
Journal Article
Trials, ISSN 1745-6215, 2016, Volume 17, Issue 1, pp. 170 - 170
Background: Methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia is a serious infection resulting in 20-50 % 90 day mortality. The limitations of... 
Flucloxacillin | Cefazolin | Methicillin-resistant | Combination | Daptomycin | MRSA | Randomised controlled trial | Vancomycin | Cloxacillin | Staphylococcus aureus | Nafcillin | UNITED-STATES | MEDICINE, RESEARCH & EXPERIMENTAL | ACUTE KIDNEY INJURY | VITRO PHARMACOKINETIC/PHARMACODYNAMIC MODEL | PIPERACILLIN-TAZOBACTAM | INTRAVENOUS-DRUG-USERS | EMPIRICAL-THERAPY | IN-VITRO | ANTIBACTERIAL ACTIVITY | PLUS CEFTAROLINE | BETA-LACTAMS | Singapore | Humans | Clinical Protocols | Anti-Bacterial Agents - therapeutic use | Methicillin-Resistant Staphylococcus aureus - pathogenicity | Time Factors | Anti-Bacterial Agents - adverse effects | Staphylococcal Infections - microbiology | Drug Therapy, Combination | Methicillin Resistance | Cloxacillin - therapeutic use | Daptomycin - therapeutic use | Staphylococcal Infections - drug therapy | Cefazolin - therapeutic use | Methicillin-Resistant Staphylococcus aureus - drug effects | Treatment Outcome | Floxacillin - therapeutic use | New Zealand | Staphylococcal Infections - diagnosis | Vancomycin - therapeutic use | beta-Lactams - adverse effects | Israel | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Australia | beta-Lactams - therapeutic use | Research Design | Prevention | Drug resistance in microorganisms | Care and treatment | Analysis | Staphylococcus aureus infections | Clinical trials | Development and progression | Beta lactamases | Research | Health aspects | Index Medicus
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 3/2009, Volume 48, Issue 6, pp. 713 - 721
Journal Article